1,25(OH)2D2/NN
production/NN
by/IN
T/NN
lymphocytes/NNS
and/CC
alveolar/JJ
macrophages/NNS
recovered/VBN
by/IN
lavage/NN
from/IN
normocalcemic/JJ
patients/NNS
with/IN
tuberculosis/NN
./.

To/TO
compare/VB
extra-renal/JJ
1,25(OH)2D3/NN
production/NN
in/IN
different/JJ
types/NNS
of/IN
granulomatous/JJ
disease/NN
,/,
and/CC
to/TO
identify/VB
the/DT
cell/NN
types/NNS
responsible/JJ
,/,
we/PRP
have/VBP
evaluated/VBN
the/DT
conversion/NN
of/IN
25(OH)D3/NN
in/IN
1,25(OH)2D3/NN
by/IN
uncultured/JJ
cells/NNS
recovered/VBN
by/IN
bronchoalveolar/JJ
lavage/NN
and/CC
blood/NN
mononuclear/JJ
cells/NNS
from/IN
normocalcemic/JJ
patients/NNS
with/IN
sarcoidosis/NN
and/CC
tuberculosis/NN
./.
=====
1,25(OH)2D3/NN
was/VBD
produced/VBN
both/CC
by/IN
lavage/NN
cells/NNS
(/(
12/12/CD
tuberculosis/NN
patients/NNS
,/,
2/6/CD
sarcoidosis/NN
patients/NNS
)/)
and/CC
blood/NN
mononuclear/JJ
cells/NNS
(/(
3/5/CD
tuberculosis/NN
patients/NNS
,/,
0/3/CD
sarcoidosis/NN
patients/NNS
)/)
from/IN
patients/NNS
but/CC
not/RB
controls/NNS
,/,
but/CC
significantly/RB
greater/JJR
amounts/NNS
were/VBD
produced/VBN
by/IN
lavage/NN
cells/NNS
from/IN
tuberculosis/NN
patients/NNS
than/IN
those/DT
of/IN
sarcoidosis/NN
patients/NNS
(/(
P/NN
less/JJR
than/IN
0.001/CD
)/)
./.
=====
1,25(OH)2D3/NN
production/NN
by/IN
lavage/NN
cells/NNS
from/IN
tuberculosis/NN
patients/NNS
correlated/VBD
with/IN
the/DT
number/NN
of/IN
CD8+/JJ
T/NN
lymphocytes/NNS
present/JJ
but/CC
not/RB
other/JJ
cell/NN
types/NNS
./.
=====
T/NN
lymphocytes/NNS
appeared/VBD
to/TO
be/VB
an/DT
important/JJ
source/NN
of/IN
1,25(OH)2D3/NN
production/NN
,/,
since/IN
purified/VBN
T/NN
lymphocytes/NNS
from/IN
all/DT
patients/NNS
with/IN
tuberculosis/NN
produced/VBD
1,25(OH)2D3/NN
,/,
and/CC
1,25(OH)2D3/NN
production/NN
by/IN
these/DT
cells/NNS
correlated/VBD
closely/RB
with/IN
that/DT
produced/VBN
by/IN
unseparated/JJ
lavage/NN
cells/NNS
./.
=====
Because/IN
1,25(OH)2D3/NN
can/MD
improve/VB
the/DT
capacity/NN
of/IN
macrophages/NNS
to/TO
kill/VB
mycobacteria/NNS
,/,
our/PRP$
results/NNS
support/VBP
the/DT
conclusion/NN
that/IN
macrophage-lymphocyte/JJ
interactions/NNS
,/,
mediated/VBN
at/IN
least/JJS
in/IN
part/NN
by/IN
1,25(OH)2D3/NN
,/,
may/MD
be/VB
an/DT
important/JJ
component/NN
of/IN
a/DT
successful/JJ
antituberculous/JJ
immune/JJ
response/NN
./.